CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...